CD4 and tuberculosis: Thus, our data support the need for a strategy incorporating both tests, especially at lower CD4 counts (≤200 cells/mm3), given that each test independently identifies patients with active TB (in this scenario, a patient’s urine and sputum samples would be taken simultaneously and both tests would be run concurrently).